Recommended Alerts

Sign Up For Alerts

Supreme Court Overturns Reduction in Reimbursement for Outpatient Drugs Purchased by Hospitals Under 340B Program

On June 15, 2022, a unanimous United States Supreme Court decided in favor of the American Hospital Association (“AHA”) in its challenge to the 2018 and 2019 final rules of the United States Department of Health and Human Services (“HHS”) reducing the amount of reimbursement for outpatient prescription drugs provided by hospitals participating in the 340B Drug Pricing Program (“340B Program”).

Read More

COVID-19 Issues and Considerations for AMCs

Practices: Health Care

Printer-Friendly Version

Coronavirus Landing Site

This document summarizes the current key issues and considerations for AMCs arising from statutory, regulatory, and industry responses to COVID-19, and is intended to serve as a checklist for AMC legal offices, as they triage the unprecedented demands that they and their organizations more broadly face as a result of the COVID-19 crisis.

Click here to view the document.

Printer-Friendly Version

Cookie Settings